Results 21 to 30 of about 1,311,352 (316)

Relationship between periodontitis and systemic diseases: A bibliometric and visual study [PDF]

Periodontology 2000
Gaetano Isola, Alessandro Polizzi, Anton Sculean   +2 more
exaly   +2 more sources

Autoantibodies against complement C1q in systemic lupus erythemathosus [PDF]

, 2008
Complement and C1q, the first component of the classical pathway of activation of the complement system, are considered to be involved in the pathogenesis of systemic lupus erythematosus (SLE), a systemic autoimmune disease.
Bigler, Cornelia
core   +1 more source

Impact of local predisposing/precipitating factors and systemic drivers on peri-implant diseases.

, 2022
BACKGROUND Strong evidence suggests the infectious nature of peri-implant diseases occurring in susceptible hosts. Epidemiological reports, though, indicate that peri-implantitis is a site-specific entity. Hence, the significance of local factors that
Borgnakke, Wenche, Kan, Joseph Y, Kan, Joseph Y., Monje, Alberto, Alberto Monje, Joseph Y. Kan, Wenche Borgnakke   +6 more
core   +1 more source

Frequency of systemic diseases.

, 2021
Frequency of systemic diseases.
Urszula Kaczmarek (11642946), Katarzyna Skośkiewicz-Malinowska (11642943), Barbara Malicka (11642949)   +2 more
core   +1 more source

Importance of systemic diseases in dentistry

, 2023
As a dentist, it is fairly common to meet patients who suffer from systemic medical conditions or diseases that can impact oral health and dental treatment.
Wu, Hsin-Ju
core  

Acne and Systemic Diseases

EMJ Dermatology, 2015
Acne is a very common, multifactorial, complex, and chronic disease of the pilosebaceous unit that affects approximately 85% of adolescent patients and 3% of adult patients. The roles of sebaceous glands, androgens, follicular epithelial cells, Propionibacterium acnes , immune mediators, environmental factors, and genetic factors are well known in acne
Tugba Kevser Uzuncakmak, Ayse Serap Karadag, Necmettin Akdeniz   +2 more
openaire   +2 more sources

Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study

Arthritis Research & Therapy, 2017
Background Prokinetics are used to treat enteric dismotility symptoms in systemic sclerosis (SSc) patients, but they often lack adequate efficacy. The most effective prokinetics belonging to the serotonin (5-HT4) receptor agonists class were withdrawn ...
Barbara Vigone, Monica Caronni, Adriana Severino, Chiara Bellocchi, Anna Rita Baldassarri, Mirella Fraquelli, Gaia Montanelli, Alessandro Santaniello, Lorenzo Beretta   +8 more
doaj   +1 more source

COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases [PDF]

, 2022
COVID-19 infection; Corticosteroids; Systemic autoimmune diseaseInfección por COVID-19; Corticosteroides; Enfermedad autoinmune sistémicaInfecció per COVID-19; Corticosteroides; Malaltia autoimmune sistèmicaObjectives: COVID-19 outcomes in population ...
Marín Ballvé, Adela, Pallarés, Lucio, Simeón Aznar, Carmen Pilar, Marín, Adela, Sáez-Comet, Luis, Gracia, Borja Del Carmelo, Fanlo, Patricia, Sáez, Luis, del Carmelo Gracia Tello, Borja, Martinez-Lostao, Luis, Simeón, Carmen Pilar, Velilla, José   +11 more
core   +1 more source

Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes

Medicina, 2022
Background and objectives. There is a bidirectional relationship between SARS-CoV-2 infection and diabetes mellitus (DM), as people with DM are more vulnerable, and SARS-CoV-2 infections worsen the prognosis in these patients.
Oana Albai, Mirela Frandes, Alexandra Sima, Bogdan Timar, Adrian Vlad, Romulus Timar   +5 more
doaj   +1 more source

Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department

Journal of Translational Autoimmunity, 2021
Background: Knowledge about COVID-19 infections is expanding, although knowledge about the disease course and antibody formation in patients with an auto-immune disease or immunodeficiency is not fully unraveled yet.
Niels A.D. Guchelaar, Jan A.M. van Laar, Maud A.W. Hermans, Tim B. van der Houwen, Sibel Atmaca, Maurits S. van Maaren, Zana Brkic, Paul L.A. van Daele, Virgil A.S.H. Dalm, P. Martin van Hagen, Saskia M. Rombach   +10 more
doaj   +1 more source